The pledge issued Tuesday is meant to increase public confidence in any approved vaccines
WEDNESDAY, Sept. 9, 2020 (HealthDay News) — The highest ethical and scientific standards will be followed in testing and manufacturing vaccines against the new coronavirus, the top executives of nine U.S. and European drug companies promise.
In the pledge issued Tuesday and meant to increase public confidence in any approved vaccines, the executives said they will make the well-being of those getting vaccinated their top priority, the Associated Press reported.
There are concerns that the U.S. Food and Drug Administration will yield to pressure from the Trump Administration to approve a vaccine before the completion of tests to prove it is safe and effective.
The pledge was signed by the chief executive officers of Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, AstraZeneca, BioNTech, GlaxoSmithKline, and Sanofi. BioNTech has teamed with Pfizer on a vaccine now in the final stage of human testing, the AP reported.
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease
Trends Reported in Vaccination Coverage for Adolescents for 2025
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older
Adverse Event Risk Not Up With Same Day COVID-19, Flu Vaccination